(NASDAQ:BLUE) traded lower for the fourth straight session as Bank of America and J.P. Morgan downgraded the gene therapy developer after its Q3 2024 results fell short of expectations for ...

With 2025 on the horizon, investors are sharpening their focus on the year ahead, selecting portfolio additions that aim to bring solid ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.96% of ...

J.P. Morgan Chase is focused on supporting the growth of companies along the Front Range of the Rockies by advising on ...

Jake Paul and Mike Tyson aren’t the only ones who have high stakes when they meet in the boxing ring on Friday night ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 55.84% ...

JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC), a biotech company focused on modulating immune ...

Instructure is no longer trading on the New York Stock Exchange Headquartered in New York City, KKR was founded in 1976 Dragoneer has over $23 billion under management KKR and Dragoneer have closed ...

In a recent interview, J.P. Morgan CEO Jamie Dimon expressed growing concerns about what’s happening in the world today, ...

As more wealthy empty nesters stick to the North Shore rather than move to the Loop, the banking giant says they're looking ...

Investment to support newly private company’s plans for product innovation and worldwide growth SALT LAKE CITY, Nov. 13, 2024 /PRNewswire/ — Instructure Holdings, Inc. (“Instructure”), a leading ...